The significance of galectin-3 as a new basal cell marker in prostate cancer

Cell Death and Disease

Volumn 4, Issue 8, 2013, Pages

  Wang, Y ^a   Balan, V ^a   Gao, X ^a   Reddy, P G ^b   Kho, D ^a   Tait, L ^c   Raz, A ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HENRY FORD HOSPITAL   (United States)

^c WAYNE STATE UNIVERSITY   (United States)

Author keywords

AR; Basal marker; Gal 3; Prostate cancer

Indexed keywords

ANDROGEN RECEPTOR; CELL MARKER; GALECTIN 3; GELATINASE B; GLUTATHIONE TRANSFERASE; PROTEIN BCL 2;

APOPTOSIS; ARTICLE; BASAL CELL; CANCER GROWTH; CARCINOGENESIS; CELL GROWTH; CELL STRAIN LNCAP; COLONY FORMATION; CONTROLLED STUDY; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; METASTASIS; METASTASIS INHIBITION; METASTASIS POTENTIAL; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; WESTERN BLOTTING;

EID: 84882724331     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2013.277     Document Type: Article

References (52)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin 2009; 59: 225-249
2. Wang G, Wang Z, Sarkar FH, Wei W. Targeting prostate cancer stem cells for cancer therapy. Discov Med 2012; 13: 135-142
3. Long RM, Morrissey C, Fitzpatrick JM, Watson RW. Prostate epithelial cell differentiation and its relevance to the understanding of prostate cancer therapies. Clin Sci (Lond) 2005; 108: 1-11 (Pubitemid 40052280)
4. Korsten H, Ziel-van der Made A, Ma X, van der Kwast T, Trapman J. Accumulating progenitor cells in the luminal epithelial cell layer are candidate tumor initiating cells in a Pten knockout mouse prostate cancer model. PLoS One 2009; 4: E5662
5. Iwata T, Schultz D, Hicks J, Hubbard GK, Mutton LN, Lotan TL et al. MYC overexpression induces prostatic intraepithelial neoplasia and loss of Nkx3.1 in mouse luminal epithelial cells. PLoS One 2010; 5: E9427
6. Gurel B, Iwata T, Koh CM, Jenkins RB, Lan F, Van Dang C et al. Nuclear MYC protein overexpression is an early alteration in human prostate carcinogenesis. Mod Pathol 2008; 21: 1156-1167
7. Wang S, Garcia AJ, Wu M, Lawson DA, Witte ON, Wu H. Pten deletion leads to the expansion of a prostatic stem/progenitor cell subpopulation and tumor initiation. Proc Natl Acad Sci USA 2006; 103: 1480-1485 (Pubitemid 43191191)
8. Lawson DA, Zong Y, Memarzadeh S, Xin L, Huang J, Witte ON. Basal epithelial stem cells are efficient targets for prostate cancer initiation. Proc Natl Acad Sci USA 2010; 107: 2610-2615
9. Goldstein AS, Huang J, Guo C, Garraway IP, Witte ON. Identification of a cell of origin for human prostate cancer. Science 2010; 329: 568-571
10. Maitland NJ, Frame FM, Polson ES, Lewis JL, Collins AT. Prostate cancer stem cells: Do they have a basal or luminal phenotype? Horm Cancer 2011; 2: 47-61
11. Oldridge EE, Pellacani D, Collins AT, Maitland NJ. Prostate cancer stem cells: Are they androgen-responsive? Mol Cell Endocrinol 2011; 360: 14-24
12. Inohara H, Akahani S, Raz A. Galectin-3 stimulates cell proliferation. Exp Cell Res 1998; 245: 294-302 (Pubitemid 28565771)
13. ÓDriscoll L, Linehan R, Liang YH, Joyce H, Oglesby I, Clynes M. Galectin-3 expression alters adhesion, motility and invasion in a lung cell line (DLKP), in vitro. Anticancer Res 2002; 22: 3117-3125 (Pubitemid 36070082)
14. Nangia-Makker P, Nakahara S, Hogan V, Raz A. Galectin-3 in apoptosis, a novel therapeutic target. J Bioenerg Biomembr 2007; 39: 79-84 (Pubitemid 46877176)
15. Cameselle-Teijeiro J, Febles-Perez C, Sobrinho-Simoes M. Papillary and mucoepidermoid carcinoma of the thyroid with anaplastic transformation: A case report with histologic and immunohistochemical findings that support a provocative histogenetic hypothesis. Pathol Res Pract 1995; 191: 1214-1221 (Pubitemid 26060404)
16. Rios Moreno MJ, Galera-Ruiz H, De Miguel M, Lopez MI, Illanes M, Galera-Davidson H. Inmunohistochemical profile of solid cell nest of thyroid gland. Endocr Pathol 2011; 22: 35-39
17. Plzak J, Smetana K Jr., Hrdlickova E, Kodet R, Holikova Z, Liu FT et al. Expression of galectin-3-reactive ligands in squamous cancer and normal epithelial cells as a marker of differentiation. Int J Oncol 2001; 19: 59-64
18. Ellerhorst J, Troncoso P, Xu XC, Lee J, Lotan R. Galectin-1 and galectin-3 expression in human prostate tissue and prostate cancer. Urol Res 1999; 27: 362-367 (Pubitemid 29526142)
19. Mangelsdorf DJ, Thummel C, Beato M, Herrlich P, Schutz G, Umesono K et al. The nuclear receptor superfamily: The second decade. Cell 1995; 83: 835-839
20. Quigley CA, De Bellis A, Marschke KB, el-Awady MK, Wilson EM, French FS. Androgen receptor defects: Historical, clinical, and molecular perspectives. Endocr Rev 1995; 16: 271-321
21. Brinkmann AO, Blok LJ, de Ruiter PE, Doesburg P, Steketee K, Berrevoets CA et al. Mechanisms of androgen receptor activation and function. J Steroid Biochem Mol Biol 1999; 69: 307-313 (Pubitemid 29305551)
22. Balk SP. Androgen receptor as a target in androgen-independent prostate cancer. Urology 2002; 60(3 Suppl 1): 132-138; Discussion 138-139
23. Tamburrino L, Salvianti F, Marchiani S, Pinzani P, Nesi G, Serni S et al. Androgen receptor (AR) expression in prostate cancer and progression of the tumor: Lessons from cell lines, animal models and human specimens. Steroids 2012; 77: 996-1001
24. Prins GS, Birch L, Greene GL. Androgen receptor localization in different cell types of the adult rat prostate. Endocrinology 1991; 129: 3187-3199
25. Lipschutz JH, Foster BA, Cunha GR. Differentiation of rat neonatal ventral prostates grown in a serum-free organ culture system. Prostate 1997; 32: 35-42 (Pubitemid 27274358)
26. Robinson EJ, Neal DE, Collins AT. Basal cells are progenitors of luminal cells in primary cultures of differentiating human prostatic epithelium. Prostate 1998; 37: 149-160 (Pubitemid 28487898)
27. Cookson MS, Reuter VE, Linkov I, Fair WR. Glutathione S-Transferase PI (GST-pi) class expression by immunohistochemistry in benign and malignant prostate tissue. J Urol 1997; 157: 673-676 (Pubitemid 27026871)
28. Colombel M, Symmans F, Gil S, ÓToole KM, Chopin D, Benson M et al. Detection of the apoptosis-suppressing oncoprotein bc1-2 in hormone-refractory human prostate cancers. Am J Pathol 1993; 143: 390-400 (Pubitemid 24058194)
29. Liu AY, True LD, LaTray L, Nelson PS, Ellis WJ, Vessella RL et al. Cell-cell interaction in prostate gene regulation and cytodifferentiation. Proc Natl Acad Sci USA 1997; 94: 10705-10710 (Pubitemid 27430798)
30. Hendrix MJ, Seftor EA, Grogan TM, Seftor RE, Hersh EM, Boyse EA et al. Expression of type IV collagenase correlates with the invasion of human lymphoblastoid cell lines and pathogenesis in SCID mice. Mol Cell Probes 1992; 6: 59-65
31. Sreenath T, Matrisian LM, Stetler-Stevenson W, Gattoni-Celli S, Pozzatti RO. Expression of matrix metalloproteinase genes in transformed rat cell lines of high and low metastatic potential. Cancer Res 1992; 52: 4942-4947
32. Signoretti S, Waltregny D, Dilks J, Isaac B, Lin D, Garraway L et al. p63 is a prostate basal cell marker and is required for prostate development. Am J Pathol 2000; 157: 1769-1775
33. Wang Y, Nangia-Makker P, Tait L, Balan V, Hogan V, Pienta KJ et al. Regulation of prostate cancer progression by galectin-3. Am J Pathol 2009; 174: 1515-1523
34. Corona G, Baldi E, Maggi M. Androgen regulation of prostate cancer: Where are we now? J Endocrinol Invest 2011; 34: 232-243
35. Sherwood ER, Berg LA, Mitchell NJ, McNeal JE, Kozlowski JM, Lee C. Differential cytokeratin expression in normal, hyperplastic and malignant epithelial cells from human prostate. J Urol 1990; 143: 167-171 (Pubitemid 20020411)
36. Ma X, Ziel-van der Made AC, Autar B, van der Korput HA, Vermeij M, van Duijn P et al. Targeted biallelic inactivation of Pten in the mouse prostate leads to prostate cancer accompanied by increased epithelial cell proliferation but not by reduced apoptosis. Cancer Res 2005; 65: 5730-5739 (Pubitemid 40911176)
37. Wang X, Kruithof-de Julio M, Economides KD, Walker D, Yu H, Halili MV et al. A luminal epithelial stem cell that is a cell of origin for prostate cancer. Nature 2009; 461: 495-500
38. Lawson DA, Xin L, Lukacs RU, Cheng D, Witte ON. Isolation and functional characterization of murine prostate stem cells. Proc Natl Acad Sci USA 2007; 104: 181-186 (Pubitemid 46068005)
39. Mulholland DJ, Xin L, Morim A, Lawson D, Witte O, Wu H. Linšca-1CD49fhigh stem/ progenitors are tumor-initiating cells in the Pten-null prostate cancer model. Cancer Res 2009; 69: 8555-8562
40. Collins AT, Berry PA, Hyde C, Stower MJ, Maitland NJ. Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res 2005; 65: 10946-10951 (Pubitemid 41713363)
41. Pacis RA, Pilat MJ, Pienta KJ, Wojno K, Raz A, Hogan V et al. Decreased galectin-3 expression in prostate cancer. Prostate 2000; 44: 118-123 (Pubitemid 30419186)
42. Merseburger AS, Kramer MW, Hennenlotter J, Simon P, Knapp J, Hartmann JT et al. Involvement of decreased galectin-3 expression in the pathogenesis and progression of prostate cancer. Prostate 2008; 68: 72-77
43. Visakorpi T, Hyytinen E, Koivisto P, Tanner M, Keinanen R, Palmberg C et al. In vivo amplification of the androgen receptor gene and progression of human prostate cancer. Nat Genet 1995; 9: 401-406
44. Taplin ME, Bubley GJ, Shuster TD, Frantz ME, Spooner AE, Ogata GK et al. Mutation of the androgen-receptor gene in metastatic androgen-independent prostate cancer. N Engl J Med 1995; 332: 1393-1398
45. Nazareth LV, Weigel NL. Activation of the human androgen receptor through a protein kinase A signaling pathway. J Biol Chem 1996; 271: 19900-19907 (Pubitemid 26281734)
46. Brand C, Oliveira FL, Ricon L, Fermino ML, Boldrini LC, Hsu DK et al. The bone marrow compartment is modified in the absence of galectin-3. Cell Tissue Res 2011; 346: 427-437
47. Al-Awqati Q. Terminal differentiation in epithelia: The role of integrins in hensin polymerization. Annu Rev Physiol 2010; 73: 401-412
48. Liu AY, True LD, LaTray L, Ellis WJ, Vessella RL, Lange PH et al. Analysis and sorting of prostate cancer cell types by flow cytometry. Prostate 1999; 40: 192-199 (Pubitemid 29334867)
49. Nangia-Makker P, Wang Y, Raz T, Tait L, Balan V, Hogan V et al. Cleavage of galectin-3 by matrix metalloproteases induces angiogenesis in breast cancer. Int J Cancer 2010; 127: 2530-2541
50. Knapp JS, Lokeshwar SD, Vogel U, Hennenlotter J, Schwentner C, Kramer MW et al. Galectin-3 expression in prostate cancer and benign prostate tissues: Correlation with biochemical recurrence. World J Urol 2013; 31: 351-358
51. Rodriguez Faba O, Palou J. Predictive factors for recurrence progression and cancer specific survival in high-risk bladder cancer. Curr Opin Urol 2012; 22: 415-420
52. Pienta KJ, Naik H, Akhtar A, Yamazaki K, Replogle TS, Lehr J et al. Inhibition of spontaneous metastasis in a rat prostate cancer model by oral administration of modified citrus pectin. J Natl Cancer Inst 1995; 87: 348-353